Figures & data
Table 1 Antifungal Combination Therapy for Mucormycosis in Mice
Table 2 Overview on Pharmacokinetics of Current Salvage Treatment for Invasive Aspergillosis and Mucormycosis
Figure 1 Present salvage therapy recommendations for invasive aspergillosis/ mucormycosis and additional future options. *Voriconazole (4–6mg/kg/d), isavuconazole (3x 200mg d1+2, then 200mg qd), posaconazole (300mg b.i.d. day 1 table/IV then 300mg qd) caspofungin (70mg/d IV day 1 then 50mg/d), micafungin (100mg - 150mg/d), anidulafungin (200mg qd day1 the 100mg qd).
![Figure 1 Present salvage therapy recommendations for invasive aspergillosis/ mucormycosis and additional future options. *Voriconazole (4–6mg/kg/d), isavuconazole (3x 200mg d1+2, then 200mg qd), posaconazole (300mg b.i.d. day 1 table/IV then 300mg qd) caspofungin (70mg/d IV day 1 then 50mg/d), micafungin (100mg - 150mg/d), anidulafungin (200mg qd day1 the 100mg qd).](/cms/asset/5f4d4865-6186-4cdd-b7a9-ff9e389b32af/didr_a_12156891_f0001_c.jpg)